Robot-Assisted Radical Prostatectomy
Radical prostatectomy (RP) is the surgical removal of the prostate and seminal vesicles for the treatment of prostate cancer. The National Comprehensive Cancer Network (NCCN) recommends RP as an option for men in all risk groups of localized disease. With an initial series dating back to 2001, robot-assisted radical prostatectomy (RARP) was one of the earliest robotic procedures to reach clinical practice and remains one of the most commonly performed . From a technical and procedural standpoint, the transperitoneal approach to RARP represents a paradigm shift away from traditional open retropubic RP. Over time, refinements to the surgical technique have evolved, although basic principles of RARP have endured. The widespread dissemination of RARP worldwide has continued despite a scarcity of high-level evidence for its superiority compared to other surgical approaches. Outcomes exceeding 10 years post RARP have now been published reporting biochemical recurrence-free survival of 73% and cancer-specific survival of 99% . A systematic review of the literature showed reduced blood loss and transfusion rates with RARP with possible improvements in continence and potency recovery [3–5].
KeywordsProstate cancer Robotics Prostatectomy Lymph node dissection